165 related articles for article (PubMed ID: 30464190)
1. Exposure history, post-exposure prophylaxis use, and clinical characteristics of human rabies cases in China, 2006-2012.
Guo C; Li Y; Huai Y; Rao CY; Lai S; Mu D; Yin W; Yu H; Nie S
Sci Rep; 2018 Nov; 8(1):17188. PubMed ID: 30464190
[TBL] [Abstract][Full Text] [Related]
2. A multicentric community survey on animal exposures among humans in India.
Ramesh Masthi NR; Pradeep BS; Bilagumba G
Indian J Public Health; 2019 Sep; 63(Supplement):S9-S14. PubMed ID: 31603085
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.
Krzowska-Firych J; Tomasiewicz K; Kozøowska A
Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28166482
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological characteristics and post-exposure prophylaxis of human rabies in Chongqing, China, 2007-2016.
Qi L; Su K; Shen T; Tang W; Xiao B; Long J; Zhao H; Chen X; Xia Y; Xiong Y; Xiao D; Feng L; Li Q
BMC Infect Dis; 2018 Jan; 18(1):6. PubMed ID: 29295708
[TBL] [Abstract][Full Text] [Related]
5. An epidemiological study of suspected rabies exposures and adherence to rabies post-exposure prophylaxis in Eastern Thailand, 2015.
Yurachai O; Hinjoy S; Wallace RM
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007248. PubMed ID: 32106251
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and surveillance of human animal-bite injuries and rabies post-exposure prophylaxis, in selected counties in Kenya, 2011-2016.
Ngugi JN; Maza AK; Omolo OJ; Obonyo M
BMC Public Health; 2018 Aug; 18(1):996. PubMed ID: 30092769
[TBL] [Abstract][Full Text] [Related]
7. Improper wound treatment and delay of rabies post-exposure prophylaxis of animal bite victims in China: Prevalence and determinants.
Liu Q; Wang X; Liu B; Gong Y; Mkandawire N; Li W; Fu W; Li L; Gan Y; Shi J; Shi B; Liu J; Cao S; Lu Z
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005663. PubMed ID: 28692657
[TBL] [Abstract][Full Text] [Related]
8. Assessing clinicians' Post-Exposure Prophylaxis recommendations for rabies virus exposures in Hunan Province, China.
Li Y; Rainey JJ; Yang H; Tran CH; Huai Y; Liu R; Zhu H; Wang Z; Mu D; Yin W; Guo C; Shiferaw M; Chen Q; Hu S; Li Z
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009564. PubMed ID: 34228714
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological investigations of human rabies in China.
Song M; Tang Q; Wang DM; Mo ZJ; Guo SH; Li H; Tao XY; Rupprecht CE; Feng ZJ; Liang GD
BMC Infect Dis; 2009 Dec; 9():210. PubMed ID: 20025742
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of epidemiological features of human rabies in China, 2012].
Zhou H; Li Y; Mu D; Yin W; Yu H
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Mar; 36(3):205-9. PubMed ID: 25975394
[TBL] [Abstract][Full Text] [Related]
11. Rabies trend in China (1990-2007) and post-exposure prophylaxis in the Guangdong province.
Si H; Guo ZM; Hao YT; Liu YG; Zhang DM; Rao SQ; Lu JH
BMC Infect Dis; 2008 Aug; 8():113. PubMed ID: 18717989
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for human rabies in China.
Gong Z; He F; Chen Z
Zoonoses Public Health; 2012 Feb; 59(1):39-43. PubMed ID: 21824368
[TBL] [Abstract][Full Text] [Related]
13. Exposure History, Post-Exposure Prophylaxis Use, and Clinical Characteristics of Human Rabies Cases: A Twelve-Year Retrospective Review at a Tertiary Facility in Ghana.
Puplampu P; Asare AA; Seneadza NAH; Ganu VJ
West Afr J Med; 2024 Jan; 41(1):36-41. PubMed ID: 38412140
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study.
Gogtay NJ; Munshi R; Ashwath Narayana DH; Mahendra BJ; Kshirsagar V; Gunale B; Moore S; Cheslock P; Thaker S; Deshpande S; Karande S; Kumbhar D; Ravish HS; Harish BR; Pisal SS; Dhere R; Parulekar V; Blackwelder WC; Molrine DC; Kulkarni PS
Clin Infect Dis; 2018 Jan; 66(3):387-395. PubMed ID: 29020321
[TBL] [Abstract][Full Text] [Related]
15. Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors.
Diallo MK; Diallo AO; Dicko A; Richard V; Espié E
BMC Infect Dis; 2019 Apr; 19(1):321. PubMed ID: 30975098
[TBL] [Abstract][Full Text] [Related]
16. Cost of rabies post exposure prophylaxis in different healthcare settings in six states of India.
Haradanhalli RS; D Hanumanthaiah AN; Varadappa ST
Indian J Public Health; 2019 Sep; 63(Supplement):S44-S47. PubMed ID: 31603091
[TBL] [Abstract][Full Text] [Related]
17. The Thai Red Cross protocol experience in Côte d'Ivoire.
Tetchi M; Coulibaly M; Kallo V; Traoré GS; Issaka T; Joseph B; Gerber F; Lechenne M; Zinsstag J; Bonfoh B
Acta Trop; 2020 Dec; 212():105710. PubMed ID: 32941800
[TBL] [Abstract][Full Text] [Related]
18. A retrospective descriptive analysis of rabies post-exposure prophylaxis cases in Dalian from 2016 to 2017.
Song Y; Lu X; Jiang X; Zhao W; Fan Z; Kang X; Wang Y
Epidemiol Infect; 2019 Jan; 147():e197. PubMed ID: 31364531
[TBL] [Abstract][Full Text] [Related]
19. Human rabies post exposure prophylaxis in Bhutan, 2005-2008: trends and risk factors.
Tenzin ; Dhand NK; Ward MP
Vaccine; 2011 May; 29(24):4094-101. PubMed ID: 21497633
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological characteristics of human rabies in China, 2017].
Liu JJ; Duo L; Tao XY; Zhu WY
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):526-530. PubMed ID: 31177732
[No Abstract] [Full Text] [Related]
[Next] [New Search]
